GlassScriptPhysician profile
Sylvia Oleck
NPI 1689801557
$14,469.70
in general payments reported to CMS, 2019-2025
19 companies · $983 in 2025
The $983 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,882 · 2020: $1,250 · 2021: $3,101 · 2022: $431 · 2023: $1,607 · 2024: $2,217 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,399 · Travel and Lodging: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,398.84 |
| Travel and Lodging | $407.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,813.67 | 2019-2023 | Perclose Prostyle, Supera |
| Edwards Lifesciences Corporation | $1,759.15 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $1,587.23 | 2019-2024 | Impella |
| Medtronic, INC. | $1,387.40 | 2021-2025 | Symplicity G3, Resolute Onyx, Azure Xt Dr Mri Surescan |
| Atricure, INC. | $1,330.69 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Boston Scientific Corporation | $1,241.37 | 2019-2024 | Watchman Flx, Watchman Access System |
| Shockwave Medical, INC | $1,095.76 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $1,060.84 | 2019-2021 | |
| Penumbra, INC. | $652.06 | 2021-2024 | Indigo System |
| Medtronic Vascular, INC. | $459.18 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $431.38 | 2019-2021 | |
| Chiesi USA, INC. | $149.62 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $120.49 | 2019 | |
| Janssen Pharmaceuticals, INC | $108.94 | 2021-2022 | |
| Cardiva Medical, INC. | $105.44 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $73.94 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.04 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $22.45 | 2019 | |
| United Therapeutics Corporation | $19.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Oleck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.